| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Pamabrom |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Amisometradine |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Sulfonamide diuretic |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Aminometradine |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Chlorazanil |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Saluretic agent (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Loop diuretic (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Thiazide diuretic (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Potassium-sparing diuretic (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Uricosuric agent (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Osmotic diuretic (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Carbonic anhydrase inhibitor |
Is a |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Quinazolindiureticum |
Is a |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Mercurial diuretic (substance) |
Is a |
True |
Diuretic (substance) |
Inferred relationship |
Some |
|
| forgiftning med diuretikum |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
1 |
| Diuretic identification |
Component |
True |
Diuretic (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| saluretisk lægemiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| forgiftning med purin-diuretikum |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
2 |
| Theobromine poisoning |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Purine diuretic poisoning NOS |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Other diuretic poisoning |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Other diuretic poisoning NOS |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Harmful pattern of use of diuretic (disorder) |
Causative agent |
True |
Diuretic (substance) |
Inferred relationship |
Some |
1 |
| Thiazide diuretic poisoning |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Diuretic adverse reaction (disorder) |
Causative agent |
True |
Diuretic (substance) |
Inferred relationship |
Some |
1 |
| bivirkning af kaliumbesparende diuretika |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| bivirkning af amilorid og loop-diuretikum |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| bivirkning af diuretikum indeholdende amilorid og thiazid |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| bivirkning af spironolacton og loop-diuretikum |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| bivirkning af diuretikum indeholdende spironolacton og thiazid |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| bivirkning af triamteren og loop-diuretikum |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| bivirkning af diuretikum indeholdende triamteren og thiazid |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| allergi over for diuretikum |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| allergi over for kaliumbesparende kombinationsdiuretikum |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| allergi over for amilorid og loop-diuretikum |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| allergi over for diuretikum indeholdende amilorid og thiazid |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| allergi over for spironolacton og loop-diuretikum |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| allergi over for diuretikum indeholdende spironolacton og thiazid |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| allergi over for triamteren og loop-diuretikum |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| allergi over for diuretikum indeholdende triamteren og thiazid |
Causative agent |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Diuretic overdose |
Causative agent |
True |
Diuretic (substance) |
Inferred relationship |
Some |
1 |
| diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| kaliumbesparende diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Co-triamterzide 50mg/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Furosemide 20 mg and spironolactone 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Co-amilofruse tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Co-amilozide 5mg/50mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Hydroflumethiazide 25 mg and spironolactone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| diuretika med kalium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| bendrofluazid 2,5 mg + kalium 7,7 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| frusemid 40 mg + kalium 8 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| frusemid 20 mg + kalium 10 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| bendrofluazid 2,5 mg + kalium 8,4 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely clopamide 5 milligram and pindolol 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Co-prenozide tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| oxprenolol 160 mg + cyclopenthiazid 250 µg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| propranololhydrochlorid 160 mg + bendrofluazid 5 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Product containing precisely hydrochlorothiazide 12.5 milligram and losartan potassium 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| amilorid + loop-diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| diuretikum indeholdende amilorid og thiazid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| nadolol + diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| oxprenolol + diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| pindolol + diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| propranolol + diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| sotalolhydrochlorid + diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| spironolacton + loop-diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| diuretikum indeholdende spironolacton og thiazid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| timololmaleat + diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| triamteren + loop-diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| diuretikum indeholdende triamteren og thiazid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Co-triamterzide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Co-amilozide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Product containing hydroflumethiazide and spironolactone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| kombinationspræparat, amiloridhydrochlorid + furosemid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Product containing cyclopenthiazide and oxprenolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| angiotensin II-receptor-antagonist + diuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| purindiuretikum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| quinazolindiuretikumprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Uricosuric product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Hydrochlorothiazide + timolol maleate 25mg/10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Bendrofluazide - chemical |
Is a |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
| Hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diuretic (substance) |
Inferred relationship |
Some |
|
FHIR